600222
vs
S
Shanghai Composite
600222
Over the past 12 months, Henan Taloph Pharmaceutical Stock Co Ltd has outperformed Shanghai Composite, delivering a return of +24% compared to the Shanghai Composite's +23% growth.
Stocks Performance
600222 vs Shanghai Composite
Performance Gap
600222 vs Shanghai Composite
Performance By Year
600222 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Henan Taloph Pharmaceutical Stock Co Ltd
Glance View
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing industry. The company is headquartered in Zhengzhou, Henan and currently employs 2,209 full-time employees. The firm provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The firm's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The firm distributes its products mainly within domestic market.